The stories of the heroes behind these and other dermatologic therapeutic discoveries are recounted in the book To Heal the Skin: The Heroes Behind Discoveries in Dermatology edited by the late Stuart Maddin, M.D., F.R.C.P.C., professor emeritus at the University of British Columbia (UBC) in Vancouver, Canada, and a leader and pioneer in dermatology in Canada and internationally, and Eileen Murray, M.D., F.R.C.P.C., a dermatologist and adjunct professor at UBC. Learn more
Dermatology Times editorial advisor, Dr. Elaine Siegfried continues the discussion on isotretinoin with Jim Leyden, M.D., emeritus professor of dermatology at the University of Pennsylvania. In this final segment, the two discuss whether a waiting period is necessary before treating acne scars and the questionable existence of pityrosporum folliculitis.
New research indicates that treatment results for patients with mild-to-moderate acne might be better with combinations of light colors with photodynamic therapy (PDT).
New and exciting topical and oral therapeutic agents and those still in the pipeline are slated to revolutionize acne therapy, as they appear to more effectively improve the clinical symptoms of acne.
In part three of the discussion on isotretinoin, our experts discuss distinguishing sinus tracts or keratinous cysts from nodular areas of inflammation and techniques for treating via intralesional injection.
The treatment and management of acne and rosacea in patients with skin of color can be tricky and it behooves the astute clinician to be wary of the pitfalls and challenges associated with treatment.
The cumulative dose of antibiotics prescribed to treat acne can be reduced through adjunctive use of retinoids or benzoyl peroxide.
Dermatology Times editorial advisor, Dr. Elaine Siegfried continues the discussion on isotretinoin with James Leyden, M.D., emeritus professor of dermatology at the University of Pennsylvania. Here, the two discuss isotretinoin dosing and side effects.
Hormonal therapy is effective in treating acne, but patients will likely have to remain on hormonal therapy long-term to maintain the benefits.